HRTX icon

Heron Therapeutics
HRTX

Overview Fund Activity

165 hedge funds and large institutions have $274M invested in Heron Therapeutics in 2025 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 50 increasing their positions, 46 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
165
Holders Change
+4
Holders Change %
+2.48%
% of All Funds
2.24%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
26
Increased
50
Reduced
46
Closed
18
Calls
$4.21M
Puts
$171K
Net Calls
+$4.04M
Net Calls Change
-$511K

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$6.61M
2
ACM
2
AIGH Capital Management
Maryland
$6.11M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$10.5M
4
PCM
4
Palisade Capital Management
New Jersey
$11.6M
5
Millennium Management
5
Millennium Management
New York
$3.07M

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$4.25M
2
CC
2
Clearline Capital
New York
$2.33M
3
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$6.57M
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$17.3M
5
OCM
5
Orchard Capital Management
Illinois
$3.15M
Name Holding Trade Value Shares
Change 		Shares
Change %
CFGS
176
Concourse Financial Group Securities
Alabama
– -$2.09K -1,280 Closed
AAP
177
Arax Advisory Partners
Colorado
– -$1.58K -1,035 Closed
RS
178
R Squared
Hong Kong
– -$1.52K -990 Closed
Jones Financial Companies
179
Jones Financial Companies
Missouri
– -$728 -476 Closed
HNB
180
Huntington National Bank
Ohio
– -$566 -370 Closed
EBA
181
Eagle Bay Advisors
New York
– -$295 -193 Closed
GM
182
GeoWealth Management
Illinois
– -$265 -173 Closed
IA
183
IFP Advisors
Florida
– -$54 -35 Closed
4 5 6 7
8